Tzeng SL

No ORCID on file · 2 papers in corpus

other 2022

Repurposing gestrinone for tumor suppressor through P21 reduction regulated by JNK in gynecological cancer

Translational research : the journal of laboratory and clinical medicine ·doi:10.1016/j.trsl.2021.12.002

Endometriosis has been shown to increase the risk of gynecological cancers. However, the effect of gestrinone, a clinical endometriosis drug, on gynecological cancers remains unclear. This study aimed to understand the effect of gestrinone …

2018

GnRH agonist long protocol versus GnRH antagonist protocol for various aged patients with diminished ovarian reserve: A retrospective study.

PloS one ·doi:10.1371/journal.pone.0207081

This retrospective analysis compared the efficiency of the gonadotropin- releasing hormone (GnRH) antagonist (GnRH-ant) protocol and the GnRH agonist long (GnRH-a) protocol for patients with diminished ovarian reserve (DOR). A total of 1,23…